Welcome to Holly Springs, North Carolina— home to Roche/Genentechs largest-ever investment: a $2B greenfield start-up where next-generation technology, high-performing teams and Operational Excellence converge to create the global standard for high-volume, highly-efficient Drug Product manufacturing. The
Build our future together: Regeneron is seeking a Principal MSAT Engineer to join our Process Sciences Drug Product Engineering department. This role supports and/or leads equipment selection, CMO selection strategy, management of equipment qualification and/or process validation
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where Health for all Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
Welcome to Holly Springs, North Carolina— home to Roche/Genentechs largest-ever investment: a $2B greenfield start-up where next-generation technology, high-performing teams and Operational Excellence converge to create the global standard for high-volume, highly-efficient Drug Product manufacturing. The
About Allogene: Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a
Who We Are BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health. Since our founding in 1997, we have applied